MODERNA INC (MRNA) Stock Earnings Estimates

NASDAQ:MRNA • US60770K1079

42.23 USD
+2.12 (+5.29%)
At close: Feb 13, 2026
42.3482 USD
+0.12 (+0.28%)
After Hours: 2/13/2026, 8:26:57 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MRNA revenue by date.MRNA revenue by date.
19.263B
4.29%
6.848B
-64.45%
3.236B
-52.75%
1.927B
-40.45%
2.05B
6.38%
2.348B
14.54%
3.288B
40.03%
5.513B
67.67%
7.706B
39.78%
6.138B
-20.35%
6.98B
13.72%
7.681B
10.04%
EBITDA
YoY % growth
MRNA ebitda by date.MRNA ebitda by date.
9.768B
-27.79%
-1.418B
-114.52%
-3.261B
-129.97%
-3.185B
2.32%
-2.745B
13.82%
-1.848B
32.68%
28.56M
101.55%
1.113B
3,797.06%
1.828B
64.24%
2.337B
27.84%
2.946B
26.06%
3.572B
21.25%
EBIT
YoY % growth
MRNA ebit by date.MRNA ebit by date.
9.42B
-29.15%
-2.039B
-121.65%
-3.45B
-69.20%
-3.462B
-0.34%
-2.981B
13.90%
-2.152B
27.80%
-1.359B
36.85%
-46.331M
96.59%
1.253B
2,804.47%
1.076B
-14.13%
1.662B
54.46%
2.023B
21.72%
Operating Margin
MRNA operating margin by date.MRNA operating margin by date.
48.90%-29.78%-106.61%-179.65%-145.40%-91.66%-41.33%-0.84%16.26%17.53%23.81%26.34%
EPS
YoY % growth
MRNA eps by date.MRNA eps by date.
19.96
-29.45%
-12.41
-162.17%
-9.28
25.22%
-8.14
12.27%
-7.11
12.65%
-5.09
28.37%
-2.97
41.80%
1.26
142.45%
4.56
262.07%
3.38
-25.84%
4.58
35.41%
5.18
13.30%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-2.33
7.43%
-2.39
-12.26%
-1.13
-121.43%
-1.28
39.44%
Revenue
Q2Q % growth
257.85M
138.75%
126.12M
-11.18%
911.82M
-10.25%
706.85M
4.26%
EBITDA
Q2Q % growth
-832.607M
14.08%
-903.76M
-16.92%
-454.794M
-910.65%
N/A
EBIT
Q2Q % growth
-926.993M
8.04%
-958.206M
-10.27%
-481.092M
-149.27%
-629.215M
42.84%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
-2.11
27.49%
-2.700.5921.71%
Q3 2025
Q2Q % growth
-0.51
-1,800.00%
-2.151.6476.27%
Q2 2025
Q2Q % growth
-2.13
36.04%
-3.030.9029.60%
Q1 2025
Q2Q % growth
-2.52
17.92%
-3.200.6821.22%
Q4 2024
Q2Q % growth
-2.91
-629.09%
-2.74-0.17-6.26%
Q3 2024
Q2Q % growth
0.03
100.31%
-1.951.98101.54%
Q2 2024
Q2Q % growth
-3.33
8.01%
-3.450.123.51%
Q1 2024
Q2Q % growth
-3.07
-1,715.79%
-3.660.5916.04%
Q4 2023
Q2Q % growth
0.55
-84.76%
-0.991.54155.49%
Q3 2023
Q2Q % growth
-9.53
-476.68%
-1.97-7.56-384.77%
Q2 2023
Q2Q % growth
-3.62
-169.08%
-4.120.5012.15%
Q1 2023
Q2Q % growth
0.19
-97.79%
-1.812.00110.52%
Q4 2022
Q2Q % growth
3.61
-68.02%
4.77-1.16-24.31%
Q3 2022
Q2Q % growth
2.53
-67.14%
3.36-0.83-24.66%
Q2 2022
Q2Q % growth
5.24
-18.89%
4.640.6012.94%
Q1 2022
Q2Q % growth
8.58
202.11%
5.323.2661.43%
Q4 2021
Q2Q % growth
11.29
1,736.23%
10.101.1911.80%
Q3 2021
Q2Q % growth
7.70
1,405.08%
9.23-1.53-16.58%
Q2 2021
Q2Q % growth
6.46
2,183.87%
6.070.396.35%
Q1 2021
Q2Q % growth
2.84
911.43%
2.430.4116.66%
Q4 2020
Q2Q % growth
-0.69 -0.35-0.34-95.61%
Q3 2020
Q2Q % growth
-0.59 -0.43-0.16-35.84%
Q2 2020
Q2Q % growth
-0.31 -0.360.0513.37%
Q1 2020
Q2Q % growth
-0.35 -0.360.012.79%
MRNA Yearly EPS VS EstimatesMRNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 10 -10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
678M
-29.81%
638.62M39.38M6.17%
Q3 2025
Q2Q % growth
1.016B
-45.44%
904.27M111.73M12.36%
Q2 2025
Q2Q % growth
142M
-41.08%
115.2M26.8M23.26%
Q1 2025
Q2Q % growth
108M
-35.33%
108.32M-320K-0.30%
Q4 2024
Q2Q % growth
966M
-65.64%
961.7M4.3M0.45%
Q3 2024
Q2Q % growth
1.862B
1.69%
1.275B587M46.04%
Q2 2024
Q2Q % growth
241M
-29.94%
134.83M106.17M78.74%
Q1 2024
Q2Q % growth
167M
-91.03%
99.451M67.549M67.92%
Q4 2023
Q2Q % growth
2.811B
-44.71%
2.545B266M10.45%
Q3 2023
Q2Q % growth
1.831B
-45.57%
1.432B399M27.86%
Q2 2023
Q2Q % growth
344M
-92.76%
326.03M17.97M5.51%
Q1 2023
Q2Q % growth
1.862B
-69.30%
1.202B660M54.91%
Q4 2022
Q2Q % growth
5.084B
-29.50%
5.118B-34M-0.66%
Q3 2022
Q2Q % growth
3.364B
-32.30%
3.597B-233M-6.48%
Q2 2022
Q2Q % growth
4.749B
9.07%
4.147B602M14.52%
Q1 2022
Q2Q % growth
6.066B
213.16%
4.709B1.357B28.82%
Q4 2021
Q2Q % growth
7.211B
1,163.54%
6.928B283M4.08%
Q3 2021
Q2Q % growth
4.969B
3,046.93%
6.331B-1.362B-21.51%
Q2 2021
Q2Q % growth
4.354B
6,457.23%
4.292B62M1.44%
Q1 2021
Q2Q % growth
1.937B
22,959.52%
2.078B-141M-6.79%
Q4 2020
Q2Q % growth
570.7M 285M285.7M100.25%
Q3 2020
Q2Q % growth
157.9M 79.063M78.837M99.71%
Q2 2020
Q2Q % growth
66.4M 27.977M38.423M137.34%
Q1 2020
Q2Q % growth
8.4M 17.432M-9.032M-51.81%
MRNA Yearly Revenue VS EstimatesMRNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS2.86% 9.24% 0.91% 18.04%
Revenue-3.18% -16.42% -0.57% -0.31%